Insilico Medicine Announces Open-Source Longevity Grok AI System

What happened

On November 6, 2026, Insilico Medicine introduced Longevity Grok, an open-source AI platform designed to organize health records, suggest possible interventions, and evaluate biomarker outcomes. The system uses up to 30 Grok Bot agents and was developed in collaboration with Harvard Medical School's David Sinclair. The software is available for free under an MIT license but requires users to have an xAI Grok Bot account. The announcement formalized the release of code that had already been made public at the end of October 2026.

Key details

• Longevity Grok uses up to 30 Grok Bot agents, including 8 core bots and 13 optional specialists.
• The public code repositories were posted on October 30, 2026; version 0.2.0 was released on November 5, 2026.
• The system supports personal, clinical, and research use, with clinic and lab tools available by invitation.
• Personal data sharing for research is opt-in and uses pseudonymous contributor codes, with strict privacy controls.
• The software is for research and educational purposes only and does not provide diagnoses or medical treatment.

Why it matters

Researchers, clinicians, and individuals interested in aging can now use Longevity Grok to organize health data and test interventions in a structured, privacy-controlled environment. The opt-in network allows users to contribute data pseudonymously, supporting large-scale research while protecting personal information. Only those with an xAI Grok Bot account can access the system, and clinical decisions remain the responsibility of licensed physicians.